Saturday, May 31, 2025

Latest

Clover Health Looks To Raise Up To $300 Million

Clover Health (NASDAQ: CLOV) announced last night the pricing for its proposed public offering of common stock. The financing will see the company look to raise gross proceeds of up to US$300 million.

Under the terms of the financing, the company intends to sell up to 52.2 million Class A common shares, with shares to be sold at a price of $5.75 per each. No warrant is being offered in connection with the financing.

The firm has also granted a 30 day over-allotment option, which could see the sale of up to an additional 7.8 million shares under the offering.

Proceeds from the sale are said to be used for working capital and general corporate purposes. The financing is expected to close on November 22.

Clover Health last traded at $6.43 on the Nasdaq.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

How To Profit From $3300 Gold? An Inside Look At A Massive 300,000 Oz Project | Martino De Ciccio

We’re At The Start of a Great Silver Boom | Ross McElroy & Andy Bowering – Apollo Silver Corp

Equinox Gold Q1 Earnings: When Everything Goes Wrong

Recommended

ESGold Begins Concentration Tests Ahead Of First Production

Sterling Metals Hits 0.21% Copper Over 482.8 Metres In First Drilling At Soo Copper project

Related News

Clover Health Versus Hindenburg Research

SPAC product Clover Health (NASDAQ: CLOV) has found itself in a long winded back-and-forth with...

Saturday, February 13, 2021, 08:30:00 AM